121 related articles for article (PubMed ID: 10765001)
1. Differential alterations of spontaneous and stimulated 45Ca(2+) uptake by platelets from patients with type I and type II diabetes mellitus.
Gill JK; Fonseca V; Dandona P; Mikhailidis DP; Angelini GD; Jeremy JY
J Diabetes Complications; 1999; 13(5-6):271-6. PubMed ID: 10765001
[TBL] [Abstract][Full Text] [Related]
2. Differential changes in alpha- and beta-adrenoceptor linked [45Ca2+] uptake in platelets from patients with anorexia nervosa.
Gill J; DeSouza V; Wakeling A; Dandona P; Jeremy JY
J Clin Endocrinol Metab; 1992 Feb; 74(2):441-6. PubMed ID: 1346146
[TBL] [Abstract][Full Text] [Related]
3. Adrenoceptor-linked [45Ca2+] uptake in platelets from diabetic rats: a model for human platelets.
Gill J; Thompson CS; Jeremy JY; Mikhailidis DP
Lab Anim; 1994 Apr; 28(2):143-7. PubMed ID: 8035565
[TBL] [Abstract][Full Text] [Related]
4. Increased intracellular calcium mobilization in platelets from patients with type 2 (non-insulin-dependent) diabetes mellitus.
Ishii H; Umeda F; Hashimoto T; Nawata H
Diabetologia; 1991 May; 34(5):332-6. PubMed ID: 1907585
[TBL] [Abstract][Full Text] [Related]
5. Atypical β- and α(2)-adrenoceptor Activation, Dibutyryl cAMP and Iloprost Stimulate [(45)Ca(2+)] Uptake by Human Platelets.
Gill J; Dandona P; Jeremy JY
Platelets; 1991; 2(2):93-8. PubMed ID: 21047284
[TBL] [Abstract][Full Text] [Related]
6. Platelet hyperactivity and abnormal Ca(2+) homeostasis in diabetes mellitus.
Li Y; Woo V; Bose R
Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1480-9. PubMed ID: 11247757
[TBL] [Abstract][Full Text] [Related]
7. Role of protein kinases in mediating [(45)ca(2+)] uptake by human platelets.
Gill J; Jeremy JY; Mikhailidis DP
Platelets; 1993; 4(6):316-21. PubMed ID: 21043600
[TBL] [Abstract][Full Text] [Related]
8. Lisinopril and nifedipine administration inhibits the ex vivo uptake of [45Ca2+] by platelets from hypertensive diabetic patients.
Gill J; Fonseca V; Dandona P; Jeremy JY
Br J Clin Pharmacol; 1992 Feb; 33(2):161-5. PubMed ID: 1312854
[TBL] [Abstract][Full Text] [Related]
9. Platelet hyper- and hypoaggregability in different microangiopathic complications of diabetes mellitus.
Szénási P; Tóth L; Romics L; Kammerer L
Acta Diabetol Lat; 1988; 25(1):7-12. PubMed ID: 3407379
[TBL] [Abstract][Full Text] [Related]
10. Platelet free cytosolic calcium concentration during ageing of type 2 diabetic patients.
Alexandru N; Popov D; Sbarcea A; Amuzescu M
Platelets; 2007 Nov; 18(7):473-80. PubMed ID: 17957564
[TBL] [Abstract][Full Text] [Related]
11. Cytosolic Ca profile of resting and thrombin-stimulated platelets from black women with NIDDM.
Zentay Z; Raguwanshi M; Reddi A; Lasker N; Dasmahapatra A; Aviv A
J Diabetes Complications; 1995; 9(2):74-80. PubMed ID: 7599351
[TBL] [Abstract][Full Text] [Related]
12. Platelet free Ca2+ concentration in non-insulin-dependent diabetes mellitus.
Yamaguchi T; Kadono K; Tetsutani T; Yasunaga K
Diabetes Res; 1991 Oct; 18(2):89-94. PubMed ID: 1841817
[TBL] [Abstract][Full Text] [Related]
13. Increase in the cytosolic concentration of calcium in platelets of diabetics type II.
Tschöpe D; Rösen P; Gries FA
Thromb Res; 1991 Jun; 62(5):421-8. PubMed ID: 1896961
[TBL] [Abstract][Full Text] [Related]
14. Deranged platelet calcium homeostasis in poorly controlled IDDM patients.
Pellegatta F; Folli F; Ronchi P; Caspani L; Galli L; Vicari AM
Diabetes Care; 1993 Jan; 16(1):178-83. PubMed ID: 8422772
[TBL] [Abstract][Full Text] [Related]
15. An analysis of the mechanism of local anesthetic inhibition of platelet aggregation and secretion.
Feinstein MG; Fiekers J; Fraser C
J Pharmacol Exp Ther; 1976 Apr; 197(1):215-28. PubMed ID: 772186
[TBL] [Abstract][Full Text] [Related]
16. Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control.
Watala C; Golanski J; Pluta J; Boncler M; Rozalski M; Luzak B; Kropiwnicka A; Drzewoski J
Thromb Res; 2004; 113(2):101-13. PubMed ID: 15115665
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide generation mediated by beta-adrenoceptors is impaired in platelets from patients with Type 2 diabetes mellitus.
Queen LR; Ji Y; Goubareva I; Ferro A
Diabetologia; 2003 Nov; 46(11):1474-82. PubMed ID: 14574451
[TBL] [Abstract][Full Text] [Related]
18. Aequorin-detected calcium changes in stimulated thrombasthenic platelets. Aggregation-dependent calcium movement in response to ADP.
Lecompte T; Potevin F; Champeix P; Morel MC; Favier R; Hurtaud MF; Schlegel N; Samama M; Kaplan C
Thromb Res; 1990 Jun; 58(6):561-70. PubMed ID: 2117306
[TBL] [Abstract][Full Text] [Related]
19. Influence of adrenoceptor stimulation on aggregation of platelets from diabetic and control rats.
Austin CE; Otter DJ; Chess-Williams R
J Auton Pharmacol; 1995 Jun; 15(3):169-76. PubMed ID: 7673271
[TBL] [Abstract][Full Text] [Related]
20. In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine.
Alarayyed NA; Cooper MB; Prichard BN; Betteridge DJ; Smith CC
Br J Clin Pharmacol; 1997 Apr; 43(4):415-20. PubMed ID: 9146854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
